WTO agreement on access to low-cost drugs

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.429, 2003-01, pp. : 12-12

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

EU price controls, low-cost drugs for developing countries

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 416, 2003-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Access to High‐Cost Drugs: Decision Makers' Perspectives

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 35, Iss. 1, 2005-03 ,pp. : 18-20

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pharma companies offer drugs at low or no cost

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 395, 2003-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Demand for low-cost antiretrovirals continues

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 330, 2001-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

WHO's low-cost strategies to prevent noncommunicable diseases

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 638, 2011-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite